These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22511776)

  • 21. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not.
    Paréj K; Dobó J; Závodszky P; Gál P
    Mol Immunol; 2013 Jul; 54(3-4):415-22. PubMed ID: 23399388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.
    Dobó J; Szakács D; Oroszlán G; Kortvely E; Kiss B; Boros E; Szász R; Závodszky P; Gál P; Pál G
    Sci Rep; 2016 Aug; 6():31877. PubMed ID: 27535802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/
    Machida T; Sakamoto N; Ishida Y; Takahashi M; Fujita T; Sekine H
    Front Immunol; 2018; 9():1191. PubMed ID: 29892304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a structure-based comprehension of the lectin pathway of complement.
    Kjaer TR; Thiel S; Andersen GR
    Mol Immunol; 2013 Dec; 56(3):222-31. PubMed ID: 23810291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
    Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
    J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
    Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
    J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components.
    Thiel S; Jensen L; Degn SE; Nielsen HJ; Gál P; Dobó J; Jensenius JC
    Clin Exp Immunol; 2012 Jul; 169(1):38-48. PubMed ID: 22670777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function.
    Degn SE; Jensen L; Hansen AG; Duman D; Tekin M; Jensenius JC; Thiel S
    J Immunol; 2012 Oct; 189(8):3957-69. PubMed ID: 22966085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity.
    Thiel S; Kolev M; Degn S; Steffensen R; Hansen AG; Ruseva M; Jensenius JC
    J Immunol; 2009 Mar; 182(5):2939-47. PubMed ID: 19234189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification, crystallization and preliminary X-ray analysis of human mannose-binding lectin-associated serine protease-1 (MASP-1) catalytic region.
    Dobó J; Harmat V; Sebestyén E; Beinrohr L; Závodszky P; Gál P
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):781-4. PubMed ID: 18765903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A journey through the lectin pathway of complement-MBL and beyond.
    Garred P; Genster N; Pilely K; Bayarri-Olmos R; Rosbjerg A; Ma YJ; Skjoedt MO
    Immunol Rev; 2016 Nov; 274(1):74-97. PubMed ID: 27782323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.
    Sørensen R; Thiel S; Jensenius JC
    Springer Semin Immunopathol; 2005 Nov; 27(3):299-319. PubMed ID: 16189649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decoupling of carbohydrate binding and MASP-2 autoactivation in variant mannose-binding lectins associated with immunodeficiency.
    Wallis R; Lynch NJ; Roscher S; Reid KB; Schwaeble WJ
    J Immunol; 2005 Nov; 175(10):6846-51. PubMed ID: 16272342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides.
    Dürvanger Z; Boros E; Nagy ZA; Hegedüs R; Megyeri M; Dobó J; Gál P; Schlosser G; Ángyán AF; Gáspári Z; Perczel A; Harmat V; Mező G; Menyhárd DK; Pál G
    ACS Chem Biol; 2022 Apr; 17(4):969-986. PubMed ID: 35378038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.
    Schwaeble WJ; Lynch NJ; Clark JE; Marber M; Samani NJ; Ali YM; Dudler T; Parent B; Lhotta K; Wallis R; Farrar CA; Sacks S; Lee H; Zhang M; Iwaki D; Takahashi M; Fujita T; Tedford CE; Stover CM
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7523-8. PubMed ID: 21502512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway.
    Iwaki D; Kanno K; Takahashi M; Endo Y; Lynch NJ; Schwaeble WJ; Matsushita M; Okabe M; Fujita T
    J Immunol; 2006 Dec; 177(12):8626-32. PubMed ID: 17142762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway.
    Takahashi M; Mori S; Shigeta S; Fujita T
    Adv Exp Med Biol; 2007; 598():93-104. PubMed ID: 17892207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of mannan-binding lectin associated serine protease (MASP)-2 reduces the cognitive deficits in a mouse model of severe traumatic brain injury.
    Mercurio D; Pischiutta F; Seminara S; Tribuzio F; Lisi I; Pasetto L; Bonetto V; De Simoni MG; Schwaeble W; Yaseen S; Dudler T; Zanier ER; Fumagalli S
    J Neuroinflammation; 2024 May; 21(1):141. PubMed ID: 38807149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum MASP-1 in complex with MBL activates endothelial cells.
    Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
    Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.